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Expression of mtDNA is critical for biogenesis of the oxidative phosphorylation system, but the regulatory
processes are poorly understood. Recent work in Cell (Yakubovskaya et al., 2010) reports a novel DNA-
binding fold in mitochondrial transcription termination factor 1 (MTERF1), which causes unwinding and
base eversion at its target mtDNA sequence.Mitochondrial dysfunction is an important
cause of human disease and is heavily
implicated in age-associated diseases
and aging (Larsson, 2010). Regulation
of mtDNA expression is essential for
maintaining cellular energy homeostasis
because biogenesis of the oxidative phos-
phorylation system is critically dependent
on key subunits encoded by mtDNA. For
more than two decades, MTERF1 has
been implicated in regulating transcription
termination in mammalian mitochondria,
but its molecular mode of action has
remained elusive. In a recent break-
through study published inCell, the atomic
structure of MTERF1-bound mtDNA was
solved (Yakubovskaya et al., 2010). Of
interest, the MTERF1 protein has a novel
fold, unwinds its DNA target, and causes
base eversion (Figure 1A), which is critical
for transcription termination (Yakubov-
skaya et al., 2010).
Transcription of mammalian mtDNA
occurs from a dedicated promoter on
each strand, and the long primary tran-
scripts undergo processing to release 13
mRNAs, 2 rRNAs, and 22 tRNAs (Larsson,
2010). Initiation of transcription at the
heavy-strand promoter (HSP) produces
the mitochondrial rRNAs as well as
several downstream mRNAs and tRNAs.
In the early 1980s, data from pulse-chase
labeling of mitochondrial RNAs in mam-
malian cell lines provided support for
a model whereby the rRNA genes consti-
tute a separate transcription unit. Other
studies showed that a tridecamer se-
quence in the tRNAL1 gene, located
immediately downstream of the rRNA
genes, could promote transcription termi-
nation in vitro. The factor binding this
sequence was denoted MTERF1 and
was further characterized by purification
and cloning (Fernandez-Silva et al., 1997).This new study presents the crystal
structure of MTERF1 bound to its target
sequence in the tRNAL1 gene at a resolu-
tion of 2.2 A˚ (Yakubovskaya et al., 2010).
Previous predictions had suggested that
intramolecular leucine zippers were an
important feature determining MTERF3
structure (Fernandez-Silva et al., 1997).
Unexpectedly, the new study shows that
MTERF1 instead has a novel DNA-binding
fold and an essentially modular architec-
ture consisting of eight repeated mterf
motifs (Figure 1A). Each mterf motif
contains two a helices followed by a 310
helix that together form a tilted triangle.
Hydrophic interactions between neigh-
boring motifs stabilize the protein, and
the overall structure adopts a curved
shape resembling half of a doughnut (Fig-
ure 1A). MTERF1 binds mtDNA as a mono-
mer but has an unusually long footprint
on the DNA and covers 20 base pairs.
The binding of MTERF1 leads to partial
melting of the DNA duplex with eversion
of three nucleotides. These flipped DNA
bases are stabilized by hydrogen bonds
and stacking interactions with amino
acids in the MTERF1 protein. The ob-
served base flipping is essential for effec-
tive transcription termination but is not
required for binding and bending of
mtDNA. The interactions with DNA are,
in fact, primarily electrostatic in nature,
as the negatively charged DNA backbone
interacts with positively charged grooves
on the protein surface. The structural
data explain why MTERF1 interacts with
its preferred binding site in the tRNAL1
gene and also provide an explanation for
the experimentally observed unspecific
DNA-binding activity (Park et al., 2007;
Yakubovskaya et al., 2010).
The novel structure is a very important
step toward a molecular understandingCell Metaboof MTERF1, but there is, in fact, still no
in vivo evidence showing that it regulates
mitochondrial transcription termination.
On the contrary, molecular characteriza-
tion of patients with the A3243G mutation
in the tRNAL1 gene, exhibiting mitochon-
drial myopathy, encephalopathy, lactic-
acidosis, and stroke-like episodes syn-
drome (MELAS), provides no support
for defective mitochondrial transcription
termination but instead argues that
impaired mitochondrial translation due to
defective function of the mutant tRNAL1
is of central pathophysiological impor-
tance (Chomyn et al., 1992). This finding
is surprising, as the causative A3243G
mutation in MELAS patients destroys the
MTERF1-binding site in the tRNAL1 gene
and strongly impairs transcription termi-
nation in vitro (Chomyn et al., 1992). It
cannot be excluded that the normally
occurring difference in relative abun-
dance of rRNAs and mRNAs is mainly
explained by different stabilities. If so,
termination of transcription initiated from
HSP may have no role in regulating
rRNA levels, and MTERF1 may instead
have another function in transcription or
perhaps even regulate mtDNA replication.
It is a very important aim for the future to
define the in vivo role of MTERF1 by
creating mouse knockouts in which both
copies of the repeated Mterf1 gene are
inactivated.
It has been reported that MTERF1 inter-
acts with both the binding site in the
tRNAL1 gene and with HSP to form an
mtDNA loop containing the rRNA tran-
scription unit (Martin et al., 2005). The
concept of a separate transcription unit
for the rRNA genes has recently been
questioned, as another study did not
detect binding of MTERF1 to HSP (Park
et al., 2007), and in vitro transcriptionlism 12, July 7, 2010 ª2010 Elsevier Inc. 3
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Figure 1. Structural Comparison of MTERF1 and MTERF3
(A) Overall structure of MTERF1 in complex with DNA. Cartoon representations of MTERF1 and double-
stranded DNA are colored in cyan and orange, respectively.
(B) Overall structure of MTERF3. A cartoon representation of MTERF3 with PDB accession code 3M66 is
colored in magenta.
(C) Structural alignment of MTERF1 and MTERF3. The alignment was performed using the SSM method.
Figure by Henrik Spa˚hr.
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Previewsstudies have not supported the existence
of a second HSP (Litonin et al., 2010). The
new structural data show that MTERF1
binds mtDNA as a monomer, and pro-
tein dimerization is therefore unlikely to
explain the proposed loop formation.
The original model also suggested that
MTERF1 terminates transcription initiated
from HSP; however, termination in this
direction is far less efficient than termina-
tion of in vitro transcription from the oppo-
site direction (Asin-Cayuela et al., 2005).
The new structure shows that MTERF1
primarily interacts with one of the two
DNA strands, which may explain the
directional effect on transcription termina-
tion. This observation also raises the
question of whether MTERF1 actually
functions to terminate transcription initi-
ated from light-strand promoter (LSP) to
avoid formation of RNAs that are anti-
sense to the rRNAs.
There is a family of four MTERF1-
related factors in mammalian mitochon-4 Cell Metabolism 12, July 7, 2010 ª2010 Elsdria, and at least two of these, MTERF2
and MTERF3, are implicated in transcrip-
tion regulation, whereas the function of
MTERF4 remains to be characterized.
The MTERF3 protein binds the promoter
region of mtDNA, and immunodepletion
of MTERF3 in mitochondrial extracts
leads to activation of mitochondrial
transcription (Park et al., 2007). Germ-
line ablation of the Mterf3 gene causes
embryonic lethality, and conditional
knockout of Mterf3 in the heart leads to
a massive activation of mtDNA transcrip-
tion consistent with a role in repressing
mtDNA transcription (Park et al., 2007).
Mice lacking Mterf2 are viable but
develop an imbalance in mitochondrial
transcript levels when challenged by
a ketogenic diet (Wenz et al., 2009). A
recent partial structure of MTERF3 (Spa˚hr
et al., 2010) (Figure 1B) shows a striking
similarity to the published MTERF1 struc-
ture; both have almost identical half-
doughnut shapes consisting of mterfevier Inc.motif repeats (Figure 1C). However, there
are also important differences, as only
one of the five arginines necessary for
sequence-specific DNA binding and only
one of the three amino acids that stabilize
base flipping are present in MTERF3
(Spa˚hr et al., 2010). The structural data
from MTERF1 and MTERF3 (Figures 1A–
1C), however, suggest that all members
of the MTERF family have similar folds
and bind nucleic acids. Further character-
ization of the MTERF family members will
likely lead to novel and exciting insights
into how they regulate mammalian
mtDNA gene expression.REFERENCES
Asin-Cayuela, J., Schwend, T., Farge, G., and
Gustafsson, C.M. (2005). J. Biol. Chem. 280,
25499–25505.
Chomyn, A., Martinuzzi, A., Yoneda, M., Daga, A.,
Hurko, O., Johns, D., Lai, S.T., Nonaka, I.,
Angelini, C., and Attardi, G. (1992). Proc. Natl.
Acad. Sci. USA 89, 4221–4225.
Fernandez-Silva, P., Martinez-Azorin, F., Micol, V.,
and Attardi, G. (1997). EMBO J. 16, 1066–1079.
Larsson, N.G. (2010). Annu. Rev. Biochem. 79,
683–706.
Litonin, D., Sologub, M., Shi, Y., Savkina, M.,
Anikin, M., Falkenberg, M., Gustafsson, C.M.,
and Temiakov, D. (2010). J. Biol. Chem. 285,
18129–18133.
Martin, M., Cho, J., Cesare, A.J., Griffith, J.D., and
Attardi, G. (2005). Cell 123, 1227–1240.
Park, C.B., Asin-Cayuela, J., Ca´mara, Y., Shi, Y.,
Pellegrini, M., Gaspari, M., Wibom, R., Hultenby,
K., Erdjument-Bromage, H., Tempst, P., et al.
(2007). Cell 130, 273–285.
Spa˚hr, H., Samuelsson, T., Ha¨llberg, B.M., and
Gustafsson, C.M. (2010). Biochem. Biophys. Res.
Commun., in press. 10.1016/j.bbrc.2010.04.130.
Wenz, T., Luca, C., Torraco, A., and Moraes, C.T.
(2009). Cell Metab. 9, 499–511.
Yakubovskaya, E., Mejia, E., Byrnes, J., Hambard-
jieva, E., and Garcia-Diaz, M. (2010). Cell 141,
982–993.
